JB Chemicals and Pharma gets USFDA nod for hypertension tablets
New Delhi: JB Chemicals & Pharmaceuticals has received US health regulator's nod for Atenolol tablets, used in the treatment of high blood pressure.
"The United States Food and Drug Administration (USFDA) has approved the company's supplementary Abbreviated New Drug Application (ANDA) for Atenolol tablets USP 25mg, 50mg and 100 mg," JB Chemicals & Pharmaceuticals said in a BSE filing.
The company, which plans to commercialize this product in the next quarter, said the market for the approved product is about USD 70 million.
"The company is focused on US business and this approval will help the company grow its exports," it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd